Welcome To Calpro - The Calprotectin Company

Calpro AS was founded by the inventors of the technology behind the ELISA kits for determination of calprotectin in stools and other biological materials. The company is based in Oslo and has the benefit of close professional links with many of the major clinical research departments and medical establishments in Norway, Europe and the USA.

CALPROLAB™ CALPROTECTIN ELISA, CE-MARKED

CalproLab™ – a new, improved Calprotectin ELISA Test.

The new kit has the broadest assay range on the market, giving accurate results from 25 – 2500 mg/kg with only one dilution of faecal extracts:

Reliable tool to differentiate between IBD and IBS
Assessment of inflammation activity in IBD
Monitoring response to treatment in IBD
Assessment of mucosal healing in IBD
Predictor of relapses in IBD

The assay has been validated by leading European clinics and laboratories. The CalproLab™ ELISA kit has also been validated for testing plasma/serum samples, enabling among others assessment of rheumatic diseases and distinction between bacterial and viral infections.

Keywords of special interest: PhicalTest, Calpro, Calprotectin

Next page: About Calpro AS